Post-traumatic stress disorder - Assessment and Diagnosis

Diagnosis and Assessment of PTSD Introduction Post-Traumatic Stress Disorder (PTSD) is diagnosed using standardized classification systems and assessment tools that help clinicians identify the condition reliably. Understanding how PTSD is classified, screened for, and assessed is essential for both accurate diagnosis and treatment planning. This section covers the major classification systems, diagnostic criteria, screening instruments, and biological markers associated with PTSD. Classification Systems: DSM-5 vs. ICD-11 Two major classification systems define PTSD differently, and it's important to understand their similarities and key differences. DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition) is the most widely used system in the United States. The DSM-5 classifies PTSD as a trauma- and stressor-related disorder—meaning it's grouped with other conditions that emerge following exposure to traumatic or stressful events. ICD-11 (International Classification of Diseases, 11th Edition), used globally by the World Health Organization, takes a slightly different approach. It defines PTSD using three symptom groups rather than four clusters. However, ICD-11 introduces an important distinction: it recognizes Complex PTSD (C-PTSD) as a separate diagnosis. Complex PTSD occurs when someone has experienced prolonged trauma (such as childhood abuse, domestic violence, or war), and includes additional symptoms beyond standard PTSD, such as difficulty regulating emotions, negative self-perception, and problems in relationships. The key takeaway: While DSM-5 focuses on four symptom clusters and is the standard in many clinical settings, ICD-11's recognition of Complex PTSD is increasingly important for understanding trauma responses, especially in cases of repeated or prolonged trauma. DSM-5 Symptom Clusters The DSM-5 defines PTSD using four distinct symptom clusters. Understanding each cluster helps you recognize the full range of PTSD symptoms and why a diagnosis requires symptoms from multiple areas. 1. Re-experiencing (Intrusion) This cluster involves involuntary recollection of the traumatic event. Symptoms include: Intrusive memories or flashbacks where the person feels as though the trauma is happening again Nightmares related to the trauma Severe psychological or physiological reactions when reminded of the trauma (such as panic or dissociation) Re-experiencing happens automatically and is distressing—the person doesn't choose to remember the trauma; it intrudes into consciousness. 2. Avoidance To reduce the distress caused by re-experiencing, people often avoid trauma reminders. This cluster includes: Avoidance of thoughts, conversations, or feelings about the trauma Avoidance of external reminders (places, people, activities, or situations) that trigger memories While avoidance temporarily reduces anxiety, it often maintains PTSD by preventing emotional processing of the trauma. 3. Negative Alterations in Cognition and Mood PTSD frequently involves negative changes in how people think and feel. This cluster includes: Persistent negative beliefs about oneself, others, or the world (e.g., "I am worthless," "People cannot be trusted") Persistent blame of self or others for the trauma or consequences Persistent negative emotional states (fear, anger, guilt, shame) Markedly diminished interest in significant activities Feeling detached from others or family Persistent inability to experience positive emotions This cluster often develops after the trauma and reflects fundamental shifts in worldview and self-perception. 4. Alterations in Arousal and Reactivity This cluster involves hyperarousal—the nervous system remains in a heightened state of alert. Symptoms include: Irritability or aggression Reckless or self-destructive behavior Hypervigilance (constantly scanning for danger) Exaggerated startle response Difficulty concentrating Sleep disturbance People with this cluster often feel "on edge" and ready for danger at all times. For diagnosis, DSM-5 requires at least one symptom from re-experiencing, one from avoidance, two from negative cognition/mood, and two from arousal/reactivity—and symptoms must last at least one month and cause significant functional impairment. Screening Instruments for Adults Screening tools are brief questionnaires designed to quickly identify whether someone might have PTSD. They are not diagnostic; rather, they flag probable cases that warrant further assessment. Two primary screening tools are widely used in clinical practice. Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) The PC-PTSD-5 is a 5-item yes/no questionnaire ideal for busy primary care settings. It asks whether the person: Has had nightmares or unwanted memories about the trauma Has tried to avoid situations, people, or conversations related to the trauma Has experienced unwanted memories, thoughts, or nightmares that cause distress Has felt numb or detached from others Has felt on edge or hyper-alert Because it takes only one minute to administer, the PC-PTSD-5 is useful for screening in medical clinics, emergency departments, or other non-mental-health settings. A positive screen (typically 4 or more items endorsed) indicates the need for more thorough assessment. PTSD Checklist for DSM-5 (PCL-5) The PCL-5 is a more detailed 20-item self-report measure. Unlike the PC-PTSD-5, it provides a severity score by asking respondents to rate how much they've been bothered by each symptom on a 0-4 scale. The PCL-5 can be used for: Initial screening Assessing symptom severity before treatment begins Monitoring treatment progress over time The PCL-5 is more sensitive and gives a fuller picture of symptom severity, making it particularly useful in mental health settings. Key Distinction: Screening tools are fast but less detailed. They tell you whether further assessment is needed, not what specific symptoms are present or how severe they are. If screening is positive, more thorough diagnostic interviews are necessary. Diagnostic Interviews: The Gold Standard While screening tools are efficient, they cannot provide a definitive PTSD diagnosis. Structured clinical interviews remain the gold standard because they allow clinicians to systematically assess all diagnostic criteria, clarify symptoms, rule out other conditions, and make a confident diagnostic decision. Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) The CAPS-5 is the most widely used diagnostic interview and is considered the gold standard. It is a 30-item structured interview administered by a trained clinician. Key features: Provides severity scores for each of the four symptom clusters Yields an overall PTSD severity score Includes questions about the onset and duration of symptoms Assesses functional impairment Results in a definitive diagnostic decision (PTSD present or absent) The CAPS-5 typically takes 30-60 minutes to administer and requires clinician training to ensure reliability. Other Structured Diagnostic Interviews PTSD Symptom Scale Interview (PSS-I): A brief 17-item interview structured around DSM-5 criteria Structured Clinical Interview for DSM-5 – PTSD Module (SCID-5-PTSD): Part of a broader diagnostic interview, used when assessing multiple mental health conditions <extrainfo> The distinction between clinician-administered (CAPS-5) and self-report (PCL-5) measures is important: self-report measures are useful for initial assessment and progress monitoring, but clinician interviews are more reliable for making a formal diagnosis, especially in research or forensic contexts. </extrainfo> Differential Diagnosis: Conditions That Mimic or Co-occur with PTSD PTSD symptoms overlap with many other psychiatric conditions, making differential diagnosis challenging but important. Clinicians must consider whether symptoms are best explained by PTSD or another disorder. Acute Stress Disorder (ASD) ASD is essentially PTSD's shorter-duration counterpart. If trauma symptoms emerge and persist for 3 days to 1 month, the diagnosis is ASD. After 1 month, if symptoms continue and meet full PTSD criteria, the diagnosis changes to PTSD. Many people with ASD go on to develop PTSD. Adjustment Disorder Adjustment disorder involves distress following an identifiable stressor (not necessarily a traumatic event) that is proportionate to the stressor's severity. It lacks PTSD's specific symptom clusters (re-experiencing, avoidance, etc.). If a patient has clear re-experiencing flashbacks, PTSD is more likely; if the reaction is general distress without specific trauma symptoms, adjustment disorder may apply. Major Depressive Disorder (MDD) PTSD and MDD share symptoms like negative mood, sleep disturbance, and difficulty concentrating. The key difference: MDD arises without a trauma trigger, and patients don't typically have re-experiencing symptoms (flashbacks). PTSD specifically follows trauma and includes intrusion and avoidance symptoms. Generalized Anxiety Disorder (GAD) Both involve anxiety and hyperarousal, but GAD involves worry about future events, while PTSD involves fear responses tied to past trauma. GAD doesn't include re-experiencing, flashbacks, or avoidance of trauma reminders. Obsessive-Compulsive Disorder (OCD) Both involve intrusive thoughts, but the content differs: PTSD intrusions are memories of the trauma; OCD intrusions are unwanted thoughts about contamination, harm, or other obsessions unrelated to a single trauma. OCD compulsions differ from PTSD avoidance in that they're intentional rituals rather than avoidance of triggers. Substance Use Disorders Trauma survivors often use alcohol or drugs to manage PTSD symptoms. When both conditions are present, the substance use may mask or complicate PTSD diagnosis. Careful assessment of the timeline helps: Did PTSD precede substance use (self-medication) or vice versa? Clinical Pearl: Asking about trauma history is essential. Many people with depression, anxiety, or substance use have underlying PTSD. If someone has a clear trauma history and current symptoms consistent with PTSD, that diagnosis should be prioritized in treatment planning. Biological and Neurobiological Markers Beyond clinical interviews and self-report, researchers have identified biological markers of PTSD, particularly in brain structure and function. While these are not used for diagnosis in routine practice, understanding them illuminates PTSD's biological basis. Brain Structure: The Hippocampus The hippocampus—a brain region crucial for forming new memories and contextualizing memories—is consistently found to be smaller in people with PTSD. This reduction correlates with both trauma exposure and symptom severity. The mechanism likely involves two processes: (1) trauma itself may damage the hippocampus, or (2) people with naturally smaller hippocampi may be more vulnerable to developing PTSD after trauma. This smaller volume may help explain why people with PTSD struggle with memory and have difficulty placing trauma memories in their proper context. Brain Function: The Threat Network Neuroimaging reveals characteristic patterns of brain activation in PTSD: Hyperactive Amygdala: The amygdala, which processes threat and fear, shows exaggerated activation when people with PTSD encounter trauma reminders. Even neutral stimuli that resemble trauma cues trigger heightened amygdala response. Reduced Medial Prefrontal Cortex (mPFC) Activation: The medial prefrontal cortex—involved in emotion regulation and extinguishing fear memories—shows reduced activation in people with PTSD, particularly during emotion regulation tasks. This under-activation may explain difficulty controlling fear and intrusive memories. Salience and Default Mode Network Alterations: The brain's salience network (which detects important information) shows altered connectivity with the default mode network (active during rest). This may explain why intrusive trauma memories persistently break into consciousness—the trauma memory is treated as continuously important and salient. The consequence: A hyperactive threat detector (amygdala) coupled with weak brakes (prefrontal cortex) leaves people with PTSD vulnerable to intrusion and hyperarousal. Hormonal Markers: HPA Axis Dysfunction The hypothalamic-pituitary-adrenal (HPA) axis is the body's stress response system. In PTSD, this system is dysregulated: Dexamethasone Suppression Test (DST): Cortisol—the primary stress hormone—is normally suppressed when dexamethasone (a synthetic glucocorticoid) is administered. In many people with PTSD, cortisol remains elevated despite dexamethasone, indicating HPA axis dysregulation. Interestingly, this pattern differs from major depression, where cortisol suppression is often impaired. This difference can help distinguish PTSD from depression. This dysregulation means the PTSD brain remains in a chronic state of vigilance, unable to fully "turn off" the stress response. <extrainfo> Genetic Factors Twin studies estimate that approximately 30% of the liability to develop PTSD following trauma exposure is genetic. This means that genetics influence who is vulnerable to PTSD, but trauma exposure is still required; genetics alone don't cause PTSD. </extrainfo> Child and Adolescent Assessment Instruments Assessing PTSD in children and adolescents requires developmentally appropriate instruments because younger people may express trauma symptoms differently than adults. Child PTSD Symptom Scale (CPSS) The CPSS is a 17-item self-report measure normed for children and adolescents ages 8-18. It assesses DSM-5 PTSD symptoms in language appropriate for younger respondents and can be used for screening and symptom monitoring. UCLA PTSD Reaction Index The UCLA PTSD Reaction Index is a structured interview appropriate for children and adolescents. Like the CPSS, it assesses the four DSM-5 symptom clusters but uses developmentally sensitive language and probes. Why Separate Instruments Matter: Children's PTSD may manifest as behavioral problems, regression, or play-based re-enactment rather than explicit flashbacks. Adult instruments may miss these presentations. Additionally, younger children may not have the verbal sophistication to describe intrusive thoughts; clinicians must observe and infer symptoms from behavior. Summary PTSD diagnosis relies on standardized classification systems (DSM-5 and ICD-11), structured interviews (CAPS-5 as the gold standard), and self-report measures (PCL-5). Screening tools (PC-PTSD-5) efficiently identify probable cases in non-mental-health settings. Differential diagnosis is crucial because PTSD shares features with depression, anxiety, and adjustment disorders. Biological markers—including hippocampal shrinkage, amygdala hyperactivity, prefrontal cortex under-activation, and HPA axis dysregulation—provide objective evidence of PTSD's neurobiological basis. Finally, specialized instruments for children and adolescents ensure developmentally appropriate assessment across the lifespan.